Reason: Defective Container: There is a potential for frangible components to be broken, resulting in a leak at the port when the closure is removed.
Distributed: Nationwide and Puerto RicoReason: Defective Container; This action is being taken as a precautionary measure due to the product being re-packaged in the U.S. using a filler material that (removes or blocks) less moisture than what is approved in the application.
Distributed: NationwideReason: Failed Impurity/Degradation Specification; "Related Compound C"
Distributed: NationwideReason: Marketed Without an Approved NDA/ANDA; product contains analogues of sildenafil and tadalafil which are active pharmaceutical ingredients in FDA-approved drugs used to treat erectile dysfunction (ED) making this product an unapproved new drug.
Distributed: Nationwide.Reason: Unit Dose Mispackaging: Product packaging defect which could result in code date smearing, incomplete blister card cuts, and missing or incorrectly placed liquicaps within the blisters.
Distributed: NationwideReason: Presence of Foriegn Substance:The manufacturer, West-ward Pharmaceutical, recalled product because of the presence of black spots on tablets. In response, the repackager initiated its own recall.
Distributed: GAReason: Failed Impurities/Degradation Specifications: unspecified degradation product
Distributed: NationwideReason: Cross contamination with other products: Belladonna Alkaloids with Phenobarbital Tablets contained a trace amount of Methocarbamol.
Distributed: NationwideReason: Presence of Foreign Substance: Belladonna Alkaloids with Phenobarbital Tablets with black specks comprised of degraded organic material on tablets.
Distributed: NationwideReason: Subpotent drug: Two lots of Oxycodone and Acetaminophen Capsules, USP 5/500 mg are being recalled due to low out of specification (OOS) assay result obtained at expiry (24 months) for the oxycodone portion of the product.
Distributed: Nationwide